Picture of Barinthus Biotherapeutics logo

BRNS — Barinthus Biotherapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapNeutral

Brief: Vaccitech Reports Q2 Loss Per Share Of $0.64

Aug 12 (Reuters) - Vaccitech PLC  VACC.O :
    * VACCITECH REPORTS SECOND QUARTER 2021 FINANCIAL RESULTS
AND
RECENT CORPORATE DEVELOPMENTS
    * Q2 LOSS PER SHARE $0.64
    * BELIEVES ITS CASH AND CASH EQUIVALENTS ARE SUFFICIENT TO
FUND
OPERATIONS INTO THE FIRST HALF OF 2024

Source text for Eikon:  ID:nGNXbhtxmm 
Further company coverage:  VACC.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Barinthus Biotherapeutics

See all news